FKGK11 is a potent and selective inhibitor of GVIA iPLA2 (Group VIA calcium-independent phospholipase A2). It exhibits significant biological activity by modulating phospholipid metabolism, making it a valuable tool for studying ovarian cancer and neurological disorders, including peripheral nerve injury and multiple sclerosis. Researchers can utilize FKGK11 to explore the roles of iPLA2 in disease mechanisms and therapeutic interventions.
FKGK11 is a potent and selective inhibitor of GVIA iPLA2 (Group VIA calcium-independent phospholipase A2). It exhibits significant biological activity by modulating phospholipid metabolism, making it a valuable tool for studying ovarian cancer and neurological disorders, including peripheral nerve injury and multiple sclerosis. Researchers can utilize FKGK11 to explore the roles of iPLA2 in disease mechanisms and therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
